oxazoles has been researched along with Long QT Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brussee, JM; Dingemanse, J; Fonseca, M; Huynh, C; Meyer Zu Schwabedissen, HE; Pouzol, L; Sidharta, PN | 1 |
| Alghamdi, WA; Alshaer, MH; Avaliani, Z; Barbakadze, K; Benkeser, D; Blumberg, HM; Jin, Y; Kempker, RR; Kipiani, M; Maranchick, NF; Mikiashvili, L; Peloquin, CA | 1 |
| Bothamley, G; Burman, M; Guglielmetti, L; Kunst, H; Lange, C; Tiberi, S; Togonidze, T; Wejse, C | 1 |
| Lynch, JB; Szumowski, JD | 1 |
| Bentley, D; Jordan, P; Ruf, T; Russell-Yarde, F; Sturm, S | 1 |
1 review(s) available for oxazoles and Long QT Syndrome
| Article | Year |
|---|---|
Profile of delamanid for the treatment of multidrug-resistant tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Interactions; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Long QT Syndrome; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Risk Assessment; Risk Factors; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2015 |
2 trial(s) available for oxazoles and Long QT Syndrome
| Article | Year |
|---|---|
Target engagement of the first-in-class CXCR7 antagonist ACT-1004-1239 following multiple-dose administration in mice and humans.
Topics: Administration, Oral; Animals; Dose-Response Relationship, Drug; Double-Blind Method; Female; Healthy Volunteers; Humans; Long QT Syndrome; Male; Mice; Mice, Inbred DBA; Oxazoles; Piperidines; Receptors, CXCR; Sex Characteristics | 2021 |
No evidence of QT prolongation with supratherapeutic doses of aleglitazar.
Topics: Adult; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Oxazoles; PPAR alpha; PPAR gamma; Quinolines; Thiophenes; Time Factors; Young Adult | 2012 |
3 other study(ies) available for oxazoles and Long QT Syndrome
| Article | Year |
|---|---|
The effect of anti-tuberculosis drug pharmacokinetics on QTc prolongation.
Topics: Adult; Antitubercular Agents; Diarylquinolines; Female; Humans; Long QT Syndrome; Male; Nitroimidazoles; Oxazoles; Prospective Studies; Tuberculosis, Multidrug-Resistant | 2023 |
QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study.
Topics: Antitubercular Agents; Cardiotoxicity; Cross-Sectional Studies; Diarylquinolines; Electrocardiography; Europe; Humans; Internationality; Long QT Syndrome; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant | 2018 |
Delamanid (Deltyba°) and multidrug-resistant pulmonary tuberculosis.
Topics: Antitubercular Agents; Electrocardiography; Humans; Long QT Syndrome; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |